
Bausch + Lomb Corporation
BLCO Real Time Price USDRecent trades of BLCO by members of U.S. Congress
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by BLCO's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
BLCO Revenue by Segment or Geography
New patents grants
-
Patent Title: Glycophospholipid polymeric network and use thereof Feb. 18, 2025
-
Patent Title: Intraocular lens injector assembly having shuttle assembly retaining intraocular lens in storage vial and operably presenting intraocular lens in injector assembly Oct. 29, 2024
-
Patent Title: Water extractable ophthalmic devices Feb. 13, 2024
-
Patent Title: Crosslinked polymeric network and use thereof Dec. 19, 2023
-
Patent Title: Ultrasonic needles and transducer assemblies formed of non-metal materials or a combination of materials Sep. 12, 2023
-
Patent Title: Crosslinked polymeric network and use thereof Aug. 22, 2023
-
Patent Title: Injector assembly employing compressed gas and a mechanical brake for presenting an intraocular lens to a patient Jul. 18, 2023
-
Patent Title: Glycophospholipid polymeric network and use thereof Jun. 13, 2023
-
Patent Title: Ophthalmic device packaging solutions comprising tris(hydroxymethyl)aminomethane and nonionic surfactant May. 30, 2023
-
Patent Title: Method and system of measuring toric lens axis angle Jan. 17, 2023
-
Patent Title: Ophthalmic suspension composition Dec. 27, 2022
-
Patent Title: Contact lens packaging solutions containing hydrophilic polymers endcapped with a hydrophilic and a hydrophobic group Nov. 08, 2022
-
Patent Title: Ultrasonic surgical aspiration needle assembly with molded hub Nov. 01, 2022
-
Patent Title: Crosslinked polymeric network and use thereof Aug. 23, 2022
-
Patent Title: Method and apparatus for delaying polymerisation Aug. 16, 2022
-
Patent Title: Method for obtaining contact lenses with dynamically controlled sagitta and clearance Jul. 19, 2022
-
Patent Title: Water extractable ophthalmic devices May. 31, 2022
-
Patent Title: Distance dominant intraocular lens May. 31, 2022
-
Patent Title: Method and apparatus for forming a lens Mar. 29, 2022
-
Patent Title: Method for intraocular lens injector assembly having shuttle assembly retaining intraocular lens in storage vial and operably presenting intraocular lens in injector assembly Mar. 22, 2022
-
Patent Title: Magnifier Mar. 22, 2022
-
Patent Title: Ophthalmic device packaging solutions comprising a poloxamine/erythritol mixture Feb. 22, 2022
-
Patent Title: Ophthalmic devices containing uv blocker and methods for their preparation Jul. 20, 2021
-
Patent Title: Water extractable ophthalmic devices Jun. 01, 2021
-
Patent Title: Vibrating surgical device for removal of vitreous and other tissue Apr. 27, 2021
-
Patent Title: Ultrasonic needles and transducer assemblies formed of non-metal materials or a combination of materials Mar. 02, 2021
-
Patent Title: Method for end-capping a polysiloxane prepolymer Dec. 22, 2020
-
Patent Title: High water content ophthalmic devices Oct. 27, 2020
-
Patent Title: Bepotastine compositions Aug. 11, 2020
-
Patent Title: Intraocular lens injector assembly having shuttle assembly retaining intraocular lens in storage vial and operably presenting intraocular lens in injector assembly Jul. 28, 2020
-
Patent Title: System and method for performing lens fragmentation Jul. 21, 2020
-
Patent Title: Ophthalmic devices Jun. 02, 2020
-
Patent Title: Ophthalmic suspension composition Mar. 24, 2020
-
Patent Title: Intraocular lens injector assembly including a shuttle and method of using same Feb. 11, 2020
-
Patent Title: Posterior capsulotomy using laser techniques Oct. 08, 2019
-
Patent Title: Posterior capsulotomy using laser techniques Oct. 08, 2019
-
Patent Title: Prism ballasted contact lens Apr. 30, 2019
-
Patent Title: Cast molding toric contact lenses Nov. 20, 2018
-
Patent Title: Peroxide contact lens care solution Nov. 20, 2018
-
Patent Title: Posterio capsulotomy using laser techniques Sep. 18, 2018
-
Patent Title: System and method for femto-fragmentation of a crystalline lens May. 22, 2018
-
Patent Title: Minimizing biological lipid deposits on contact lenses Apr. 17, 2018
-
Patent Title: Irrigation sleeve and phacoemulsification needle with sleeve retention features Apr. 17, 2018
-
Patent Title: Intraocular lens injector assembly including a shuttle and method of using same Apr. 03, 2018
-
Patent Title: Ophthalmic multiple wavelength laser illuminator with a graphical user interface Feb. 20, 2018
-
Patent Title: Method for preparing suspensions of low-solubility materials Oct. 03, 2017
-
Patent Title: System and method for femto-fragmentation of a crystalline lens Mar. 14, 2017
-
Patent Title: Packaging solutions Dec. 27, 2016
-
Patent Title: Vibrating surgical device for removal of vitreous and other tissue Nov. 22, 2016
-
Patent Title: Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide Nov. 01, 2016
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to BLCO
Recent picks made for BLCO stock on CNBC
ETFs with the largest estimated holdings in BLCO
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
---|
- Is $BLCO stock a Buy, Sell, or Hold?
- What is the price target for $BLCO stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
Shareholder
|
Shares Held
|
---|
- Who owns $BLCO stock?
- Who owns the most shares of $BLCO stock?
- What funds own $BLCO stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BLCO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.